ResMed, Inc. (RMD) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $222.64 -0.22%
EPS Growth %: +13.3%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
GLXY, CRVL, SGHC, More
EPS Growth %: +13.3%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
GLXY, CRVL, SGHC, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $376.5 million versus the consensus estimate of $363.76 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carlyle sees improving exit conditions for "good companies"
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- Erste Group Upgrades Abbvie (ABBV) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
